Pcas SA
PAR:PCA

Watchlist Manager
Pcas SA Logo
Pcas SA
PAR:PCA
Watchlist
Price: 8 EUR Market Closed
Market Cap: 109.9m EUR
Have any thoughts about
Pcas SA?
Write Note

Pcas SA
Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Pcas SA
Cash Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash CAGR 3Y CAGR 5Y CAGR 10Y
Pcas SA
PAR:PCA
Cash
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Sartorius Stedim Biotech SA
PAR:DIM
Cash
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Eurofins-Cerep SA
PAR:ALECR
Cash
€9.3m
CAGR 3-Years
45%
CAGR 5-Years
28%
CAGR 10-Years
14%
No Stocks Found

Pcas SA
Glance View

Market Cap
109.9m EUR
Industry
Life Sciences Tools & Services

PCAS SA engages in the development, manufacture, and sale of chemicals. The company is headquartered in Ecully, Auvergne-Rhone-Alpes. The company operates through nine production sites and two main business units, Pharma Synthesis and Fine & Specialty Chemicals. Pharma Synthesis unit specializes in active pharmaceutical ingredients (API), intermediates and building blocks, and early phase services, among others. Fine & Specialty Chemicals unit focuses on custom manufacturing and proprietary products, such as fragrance, flavor ingredients, imaging and microelectronics chemicals. The firm operates several subsidiaries, including Saint-Jean Photochimie, Societe Bearnaise de Synthese, Expansia, PCAS BioMatrix Inc, based in Canada, and PCAS Finland Oy, based in Finland, among others.

PCA Intrinsic Value
13.77 EUR
Undervaluation 42%
Intrinsic Value
Price

See Also

Back to Top